Lorazepam Spirig HC 2.5 mg, Tabletten
7680696820040
CH-69682
Tabletten
Associated product:
LORAZEPAM Spirig HC cpr 2.5 mg 50 pce
1 / 3
google
Article details
- Package size
- 50
- Selling units
- 50
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
122.8 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 16.05
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/03/2025
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 69682
- Drug name
- Lorazepam Spirig HC, Tabletten
- Galenic form
- TAB
- ATC Code
- N05BA06
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 22/08/2024
- Authorization expiration date
- 21/08/2029
- IT Number
- 01.04.1.
- Domain
- Human medicine
Package details
- Description (FR)
- LORAZEPAM Spirig HC cpr 2.5 mg 50 pce
- Description (DE)
- LORAZEPAM Spirig HC Tabl 2.5 mg 50 Stk
- Market launch
- 22/08/2024
- Narcotic (BTM)
- B
Original drug
Temesta Expidet, Lyophilisat zum Einnehmen
GTIN: 7680471020733
CHF 12.40